| | Class 2 Device Recall QIAstatDx |  |
| Date Initiated by Firm | March 12, 2025 |
| Date Posted | March 31, 2025 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-1504-2025 |
| Recall Event ID |
96521 |
| 510(K)Number | K233100 |
| Product Classification |
Multi-target respiratory specimen nucleic acid test including SARS-CoV-2 and other microbial agents - Product Code QOF
|
| Product | Brand Name: QIAstat-Dx
Product Name: QIAstat-Dx Respiratory Panel Plus
Reference Number (REF): 691224
Software Version: n/a
Component: n/a |
| Code Information |
REF 691224; Lot 178038604; UDI-DI: 04053228047438; affected Serial numbers (SNs):
332168961
332168962
332168963
332168964
332168972
332168978
332168979
332168980
332168990
332168996
332169005
332169012
332169013
332169015
332169016
332169021
332169022
332169023
332169024
332169031
332169032
332169033
332169034
332169039
332169040
332169041
332169042
332169047
332169048
332169049
332169050
332169055
332169056
332169057
332169060
332169065
332169066
332169073
332169074
332169083
332169084
332169085
332169086
332169091
332169092
332169093
332169094
332169099
332169101
332169102
332169107
332169108
332169109
332169110
332169115
332169116
332169117
332169118
332169123
332169125
332169126
332169131
332169132
332169133
332169134
332169139
332169140
332169141
332169142
332169147
332169148
332169149
332169150
332169155
332169156
332169157
332169158
332169163
332169164
332169165
332169166
332169171
332169172
332169173
332169174
332169180
332169181
332169182
332169187
332169188
332169189
332169190
332169195
332169196
332169197
332169198
332169203
332169204
332169205
332169206
332169212
332169213
332169214
332169216
332169221
332169222
332169223
332169224
332169229
332169230
332169231
332169232
332169238
332169239
332169240
332169241
332169246
332169247
332169248
332169249
332169255
332169256
332169257
332169262
332169263
332169264
332169265
332169271
332169272
332169273
332169279
332169280
332169282
332169287
332169288
332169289
332169290
332169295
332169296
332169297
332169298
332169303
332169315
332169320
332169321
332169322
332169323
332169328
332169329
332169330
332169331
332169336
332169337
332169338
332169339
332169344
332169345
332169346
332169347
332169354
332169355
332169360
332169361
332169362
332169365
332169368
332169369
332169370
332169371
332169376
332169377
332169378
332169379
332169384
332169385
332169386
332169387
332169392
332169393
332169394
332169395
332169401
332169403
332169410
332169412
332169413
332169418
332169420
332169427
332169428
332169429
332169434
332169442
332169443
332169460
332169475
332169477
332169483
332169484
332169486
|
Recalling Firm/ Manufacturer |
Qiagen Sciences LLC 19300 Germantown Rd Germantown MD 20874-1415
|
| For Additional Information Contact | QIAGEN Technical Services 800-362-7737 |
Manufacturer Reason for Recall | Identified faulty cartridges. If such a faulty cartridge is used for sample testing, false test results could occur. |
FDA Determined Cause 2 | Mixed-up of materials/components |
| Action | On March 12, 2025, "URGENT MEDICAL DEVICE CORRECTION" letters were sent to customers.
Actions to be taken by customer/user:
1. Check if you have remaining stock. DO NOT use it. Dispose of it immediately in accordance with your national and local safety and environmental regulations.
2. Contact QIAGEN Technical Services for a free-of-charge replacement.
o If you already used cartridges from this LOT, identify the results obtained with cartridges from the affected SN. For results obtained with an affected SN: Review all results of the respective targets mentioned in Detailed description of the issue, above, to identify potentially erroneous diagnosis, except in those cases where alternative confirmation was obtained.
o Review any result for which tests were performed, or treatments were given on clinical and/or epidemiological suspicion of the respective targets.
3. Review this notice with your laboratory/medical director.
4. Important: Forward this information to all individuals and departments within your organization using the above-listed kits. If you are not the end user, forward this notice to the product end user.
5. Complete the Acknowledgement of Receipt Form
Actions taken by QIAGEN:
QIAGEN was able to identify the root cause of the issue and has implemented immediate actions to ensure that the currently produced cartridges will not cause this issue moving forward.
If you have any questions or concerns, please contact your local QIAGEN Technical Services Department through any of the following: Telephone: 800 362 7737; Email: TechService-NA@qiagen.com
|
| Quantity in Commerce | 445 units |
| Distribution | US Distribution: AL, CA, DC, FL, IN, KS, KY, MA, ME, MN, NY, and TX. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = QOF
|
|
|
|